In Silico Design
Sq Suite
AI-Powered Precision
in Drug Design
Discover Sq Suite, our state-of-the-art AI/ML-augmented platform for ligand design. This versatile tool combines physics-based modeling with cutting-edge machine learning to revolutionize drug discovery.
Features for Accelerating Drug Development
Customizable protocols for diverse targets
Flexible design parameter assessment
Fine-tuned solutions for complex problems
Specialized Modules
Sq-PROT:
Designs diverse biologics (peptides, proteins, mABs)
Sq-SYNT:
Cost-efficient small-molecule discovery
Sq-AIMM:
Peptide/protein deimmunization and vaccine design
Breakthrough Achievements
- Novel oral insulin candidate in preclinical development
- Non-opiate multi-targeted analgesic with animal proof-of-concept
- Ongoing projects with
Harness the power of Sq Suite to accelerate your drug development pipeline and unlock new therapeutic possibilities. Partner with Sekkei Bio to leverage this innovative technology and stay ahead in the competitive pharmaceutical landscape.
Accelerate Drug Development
Sekkei Bio is seeking innovation partners to build
pharmaceutical technologies to revolutionize patient care.
pharmaceutical technologies to revolutionize patient care.